UBS OCONNOR LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$120,162
-56.7%
393,9750.0%0.00%
-66.7%
Q2 2023$277,358
-26.7%
393,975
-6.7%
0.01%
-25.0%
Q1 2023$378,625
-100.0%
422,102
+90.1%
0.01%
-62.5%
Q3 2022$1,672,000,000
-12.8%
222,041
-27.0%
0.03%
+14.3%
Q2 2022$1,917,000,000
+263.8%
304,300
+492.0%
0.03%
+86.7%
Q3 2019$527,000,00051,4000.02%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders